The new report includes possible therapeutic agents and vaccines for COVID-19, researchers from CAS, a division of the American Chemical Society.
Researchers at CAS, a division of the American Chemical Society, have released a special report in which they provide an overview of previously published scientific information on possible therapeutic agents and vaccines for CORID-19, the cause of SARS-VOC-2.
It is a respiratory disease that occurs. Crown… This scanning electron microscope image shows SARS-COV-2 (round gold objects) protruding from the surface of cells grown in the laboratory.
The virus shown was isolated from an American patient. The outbreak of the coronavirus disease COVID-19 represents an epidemic threat to global public health.
Although the outbreak occurred in Wuhan, China, in December 2019, the disease has spread to more than 100 countries.
Furthermore, the lives of millions of people have been affected as a result of mandatory segregation / quarantine. This scanning electron microscope image shows SARS-COV-2 (round gold objects) protruding from the surface of cells grown in the laboratory.
The virus shown was isolated from a patient in the EE image. USA By NIAID-RML. The ripple effect of the COVID-19 outbreaks can potentially bring great challenges to health systems worldwide and can have far-reaching consequences on the global economy if the spread of the virus is not effectively controlled.
SARS-CoV-2 primarily attacks the lower respiratory system to cause viral pneumonia, but it can also affect the gastrointestinal system, heart, kidneys, liver, and central nervous system.
To aid in research efforts to find therapies and vaccines for COVID-19, Dr. Cynthia Liu’s CAS and colleagues analyzed published scientific data on SARS-CoV-2 and related coronaviruses.
The scientists reviewed the growing body of journal articles related to COVID-19 and SARS-COV-2, as well as what to do with the human coronavirus.
From the last week of 2019 to March 1, 2020, more than 500 journal articles related to the virus were published electronically or in print, and the numbers steadily increased week by week.
Topics included clinical manifestations, treatment regimen, viral structure and mechanisms, antiviral agents, and diagnostics.
To date, more than 500 patents have been issued for vaccines and therapeutic agents, such as antibodies, cytokines, and nucleic acids, that can help prevent or treat coronavirus infection.
Because SARS-CoV-2 is similar to other coronaviruses, such as SARS-CoV-1 and MERS-CoV, the researchers shed light on previously discovered treatments for these other viruses that can also be applied to SARS-CoV- two.
The information included in the report provides a solid intellectual basis for the continued development of therapeutic agents and vaccines, the authors stated.
The report was published in the ACS Central Science Journal.